Actelion (XSWX:ATLNE) Ending Cash Position : CHF760 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Ending Cash Position?

Actelion's Ending Cash Position for the quarter that ended in Mar. 2017 was CHF760 Mil.

Actelion's quarterly Ending Cash Position increased from Sep. 2016 (CHF411 Mil) to Dec. 2016 (CHF495 Mil) and increased from Dec. 2016 (CHF495 Mil) to Mar. 2017 (CHF760 Mil).

Actelion's annual Ending Cash Position declined from Dec. 2014 (CHF1,205 Mil) to Dec. 2015 (CHF405 Mil) but then increased from Dec. 2015 (CHF405 Mil) to Dec. 2016 (CHF495 Mil).

Actelion Ending Cash Position Historical Data

The historical data trend for Actelion's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Ending Cash Position Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Ending Cash Position

Get a 7-Day Free Trial

1,022.27

627.64

1,204.96

404.89

495.38

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Ending Cash Position	Get a 7-Day Free Trial															471.60	418.41	410.71	495.38	759.78

Actelion Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Actelion's Ending Cash Position for the fiscal year that ended in Dec. 2016 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	404.892	+	90.488
	=	495

Actelion's Ending Cash Position for the quarter that ended in Mar. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	495.38	+	264.396
	=	760

Actelion Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Actelion's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (XSWX:ATLNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines